report-image

Cardiovascular Devices Market Analysis by Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure), By End-User (Hospitals, Specialty Clinics) and by Region: Global Forecast, 2024 - 2034.

  • PUBLISHED ON
  • 2024-08-17
  • NO OF PAGES
  • 231
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The Cardiovascular Devices market is predicted to develop at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2034, when it is projected to reach USD 112.95 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 64.88 Billion in 2024.


 

SOURCE: We Market Research

Medical instruments called cardiovascular devices are used to identify, track, and treat disorders of the heart and blood vessels. Important instances include heart valve replacement or repair, stents to maintain arterial patency, pacemakers to control cardiac rhythms, and catheters for therapeutic or diagnostic purposes such as angioplasty. Additional devices include heart pumps like LVADs to help the heart pump blood, implanted cardioverter defibrillators (ICDs) to correct severe arrhythmias, cardiac monitors to continuously observe heart activity, and electrocardiogram (ECG) equipment to record heart activity. The quality of life and overall health of patients are greatly improved by these devices in the management and treatment of cardiovascular illnesses.

The ageing population, the increasing incidence of cardiovascular illnesses, and technical developments in medical devices are the main drivers of the cardiovascular devices industry. The market is expected to rise as a result of enhanced healthcare infrastructure, regular screening for cardiac problems, increased awareness of the ailment, and encouraging government initiatives. The need for these devices is further fueled by changes in lifestyle that result in increased incidences of obesity, diabetes, and hypertension. Furthermore, growing healthcare spending encourages market expansion. Together, these elements promote the development and uptake of cardiovascular devices, enhancing patient outcomes and propelling worldwide market expansion.

Market Scope

Report Attributes

Description

Market Size in 2024

USD 64.88 Billion

Market Forecast in 2034

USD 112.95 Billion

CAGR % 2024-2034

5.7%

Base Year

2023

Historic Data

2016-2022

Forecast Period

2024-2034

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Device Type, By Application, By End-User and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

 

Cardiovascular Devices Industry: Dynamics & Restrains


 Market opportunity:


We Market Research: Cardiovascular Devices Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.


Cardiovascular Devices Segmentation

Market- By Device Type Analysis

By Device Type, the Cardiovascular Devices Market is Categories into Diagnostic and Monitoring Devices, Therapeutic and Surgical Devices. The Therapeutic and Surgical Devices segment accounts for the largest share of around 61% in 2024.


The drivers for therapeutic and surgical devices in the global cardiovascular devices market include increasing prevalence of cardiovascular diseases, advancements in technology, rising geriatric population, improved healthcare infrastructure, and growing demand for minimally invasive procedures.

The following segments are part of an in-depth analysis of the global Cardiovascular Devices market:

Market Segments

 

By   Application

·         Coronary Artery Disease (CAD)

·         Cardiac Arrhythmia

·         Heart Failure

By  End-User

·         Hospitals

·         Specialty Clinics

 

Cardiovascular Devices Industry: Regional Analysis

North America Market Forecast

North America dominate the Cardiovascular Devices Market with the highest revenue generating market with share of more than 47%. North America leads the Cardiovascular Devices market, driven by advanced healthcare infrastructure supporting extensive device usage, strong market presence of leading manufacturers, and substantial healthcare expenditure enabling adoption of advanced technologies. Challenges include high costs of devices and healthcare services.


Europe Market Statistics

Europe's Cardiovascular Devices market is second largest market. Europe has a significant share in the Cardiovascular Devices market due to increasing incidence of cardiovascular diseases due to aging population and lifestyle changes, well-established healthcare systems supporting device adoption, and favorable reimbursement policies encouraging market growth. Challenges include stringent regulatory frameworks and economic variations impacting healthcare investments.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Cardiovascular Devices market during the forecast period. In the Asia Pacific region, rapid urbanization and lifestyle changes leading to increased cardiovascular disease prevalence, improving healthcare infrastructure expanding access to devices, rising disposable incomes supporting healthcare spending, and growing awareness of heart health. Challenges include disparities in healthcare access between urban and rural areas.

Key Market Players

The Cardiovascular Devices Market is dominated by a few large companies, such as

·         Boston Scientific Corporation

·         Terumo Cardiovascular Systems Corporation

·         B. Braun Melsungen AG

·         LivaNova PLC

·         Siemens Healthcare GmbH

·         Medtronic

·         Abbott

·         Edwards Lifesciences Corporation

·         Johnson & Johnson Services, Inc.

·         GENERAL ELECTRIC COMPANY

·         Other


1.      Global Cardiovascular Devices Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Cardiovascular Devices Market Scope and Market Estimation

1.2.1. Global Cardiovascular Devices Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Cardiovascular Devices Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Device Type of Global Cardiovascular Devices Market

1.3.2. Application of Global Cardiovascular Devices Market

1.3.3. End-User of Global Cardiovascular Devices Market

1.3.4. Region of Global Cardiovascular Devices Market

2.      Executive Summary

2.1.    Market Dynamics

2.1.1. Drivers

2.1.2. Limitations

2.1.3. Opportunities

2.1.4. Impact Analysis of Drivers and Restraints

2.2.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.3.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.4.    Porter’s Five Forces Analysis

2.4.1. Bargaining Power of Suppliers

2.4.2. Bargaining Power of Buyers

2.4.3. Threat of Substitutes

2.4.4. Threat of New Entrants

2.4.5. Competitive Rivalry

2.5.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Cardiovascular Devices Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Cardiovascular Devices Market Estimates & Forecast Trend Analysis, By Device Type

4.1.    Global Cardiovascular Devices Market Revenue (US$ Mn) Estimates and Forecasts, By Device Type , 2019 to 2034

4.1.1. Diagnostic and Monitoring Devices

4.1.2. Therapeutic and Surgical Devices

5.      Global Cardiovascular Devices Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Cardiovascular Devices Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Coronary Artery Disease (CAD)

5.1.2. Cardiac Arrhythmia

5.1.3. Heart Failure

6.      Global Cardiovascular Devices Market Estimates & Forecast Trend Analysis, by End-User

6.1.    Global Cardiovascular Devices Market Revenue (US$ Mn) Estimates and Forecasts, by End-User, 2019 to 2034

6.1.1. Hospitals

6.1.2. Specialty Clinics

7.      Global Cardiovascular Devices Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Cardiovascular Devices Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Cardiovascular Devices Market: Estimates & Forecast Trend Analysis

8.1.    North America Cardiovascular Devices Market Assessments & Key Findings

8.1.1. North America Cardiovascular Devices Market Introduction

8.1.2. North America Cardiovascular Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

8.1.2.1.   By Device Type

8.1.2.2.   By Application

8.1.2.3.   By End-User

8.1.2.4.   By Country

8.1.2.4.1.     The U.S.

8.1.2.4.2.     Canada

8.1.2.4.3.     Mexico

9.      Europe Cardiovascular Devices Market: Estimates & Forecast Trend Analysis

9.1.    Europe Cardiovascular Devices Market Assessments & Key Findings

9.1.1. Europe Cardiovascular Devices Market Introduction

9.1.2. Europe Cardiovascular Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By Device Type

9.1.2.2.   By Application

9.1.2.3.   By End-User

9.1.2.4.        By Country

9.1.2.4.1.     Germany

9.1.2.4.2.     U.K.

9.1.2.4.3.     France

9.1.2.4.4.     Italy

9.1.2.4.5.     Spain

9.1.2.4.6.     Russia

9.1.2.4.7.     Rest of Europe

10.  Asia Pacific Cardiovascular Devices Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Cardiovascular Devices Market Introduction

10.1.2.   Asia Pacific Cardiovascular Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By Device Type

10.1.2.2.    By Application

10.1.2.3.    By End-User

10.1.2.4.    By Country

10.1.2.4.1. China

10.1.2.4.2. Japan

10.1.2.4.3. India

10.1.2.4.4. Australia

10.1.2.4.5. South Korea

10.1.2.4.6. ASEAN

10.1.2.4.7. Rest of Asia Pacific

11.  Middle East & Africa Cardiovascular Devices Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Cardiovascular Devices Market Introduction

11.1.2.   Middle East & Africa Cardiovascular Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By Device Type

11.1.2.2.    By Application

11.1.2.3.    By End-User

11.1.2.4.    By Country

11.1.2.4.1. U.A.E.

11.1.2.4.2. Saudi Arabia

11.1.2.4.3. Egypt

11.1.2.4.4. South Africa

11.1.2.4.5. Rest of Middle East & Africa

12.  South America Cardiovascular Devices Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Cardiovascular Devices Market Introduction

12.1.2.   South America Cardiovascular Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By Device Type

12.1.2.2.    By Application

12.1.2.3.    By End-User

12.1.2.4.    By Country

12.1.2.4.1. Brazil

12.1.2.4.2. Argentina

12.1.2.4.3. Colombia

12.1.2.4.4. Rest of South America

13.  Competition Landscape

13.1.  Global Cardiovascular Devices Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Cardiovascular Devices Market Competition White Space Analysis, By End-user

13.3.  Global Cardiovascular Devices Market Competition Heat Map Analysis, By End-user

13.4.  Global Cardiovascular Devices Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Boston Scientific Corporation

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Terumo Cardiovascular Systems Corporation

14.3.      B. Braun Melsungen AG

14.4.      LivaNova PLC

14.5.      Siemens Healthcare GmbH

14.6.      Medtronic

14.7.      Abbott

14.8.      Edwards Lifesciences Corporation

14.9.      Johnson & Johnson Services, Inc.

14.10.  GENERAL ELECTRIC COMPANY

14.11.  Other

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Cardiovascular Devices Market in 2024?

Cardiovascular Devices Market was valued at USD 64.88 Billion in 2024.

What is the growth rate for the Cardiovascular Devices Market?

Cardiovascular Devices Market size will increase at approximate CAGR of 5.7% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Cardiovascular Devices Market Are Boston Scientific Corporation,Terumo Cardiovascular Systems Corporation , B. Braun, Melsungen AG , LivaNova PLC , Siemens Healthcare GmbH , Medtronic , Abbott , Edwards Lifesciences Corporation , Johnson & Johnson Services, Inc., GENERAL ELECTRIC COMPANY and Other.

Which region dominates the Cardiovascular Devices Market?

North America dominates the market with an active share of 47%.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI